NCT05783219View on ClinicalTrials.gov

Lidocaine Patches Prior to Percutaneous Nerve Evaluation

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Overactive BladderUrge IncontinenceFecal Incontinence
Interventions
DRUG

Lidocaine patch

4% lidocaine patch placed over the sacrum 30 minutes prior to PNE procedure

OTHER

Placebo

Adhesive patch placed over the sacrum 30 minutes prior to PNE procedure

Trial Locations (2)

40205

ULP Female Pelvic Medicine and Reconstructive Surgery - Springs Medical Center Suite 190, Louisville

40215

ULP Female Pelvic Medicine and Reconstructive Surgery - Urogynecology Associates office, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT05783219 - Lidocaine Patches Prior to Percutaneous Nerve Evaluation | Biotech Hunter | Biotech Hunter